Literature DB >> 9301527

Recipient age determines the success of intraperitoneal transplantation of peritoneal cavity B cells.

P Julius1, M Kaga, Y Palmer, V Vyas, L Prior, D Delice, J Riggs.   

Abstract

In vivo studies of lymphocyte biology have used intravenous (i.v.) injection as the primary mode of cell transfer, a protocol consistent with the anatomic distribution of most lymphocytes. However, for study of peritoneal cavity B cells, i.v. injection does not correlate with anatomical localization. This report describes the restoration of B-cell function in B lymphocyte-defective X-chromosome-linked immune-defective (XID) mice after intraperitoneal transfer of immunoglobulin heavy chain (Igh)-disparate peritoneal cavity (PerC) cells. In contrast to i.v. transfer, intraperitoneal (i.p.) transfer restored B-cell function in young, but not adult (> 8 weeks), XID mice. When host and donor Igh allotype matched, PerC B-cell engraftment was noted in older recipients; this reconstitution however, was also age-dependent. Migration from the peritoneum to systemic circulation was necessary for serum IgM production as shown by the presence of donor antibody-secreting cells in the host spleen. Host lymphocytes also influenced the success of i.p. transplantation as severe combined immune-deficient mice, regardless of age, exhibited donor serum IgM production. Recipient age, Igh allotype, and immune-deficiency were found to have an impact on the ability of i.p.-transferred PerC B cells to restore B-cell function in XID mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9301527      PMCID: PMC1364007          DOI: 10.1046/j.1365-2567.1997.00270.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

Review 1.  Ionizing radiation and the immune response.

Authors:  R E Anderson; N L Warner
Journal:  Adv Immunol       Date:  1976       Impact factor: 3.543

2.  B cell dependence of the congeneic barrier towards idiotype-carrying cells.

Authors:  R Bösing-Schneider; H C Selinka; G Lehle
Journal:  Eur J Immunol       Date:  1986-11       Impact factor: 5.532

3.  The Ly-1 B cell lineage.

Authors:  L A Herzenberg; A M Stall; P A Lalor; C Sidman; W A Moore; D R Parks; L A Herzenberg
Journal:  Immunol Rev       Date:  1986-10       Impact factor: 12.988

4.  B lymphocyte differentiation in the CBA/N mouse: a delay in maturation rather than a total arrest.

Authors:  J M Fidler; E L Morgan; W O Weigle
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

Review 5.  CBA/N immune defective mice; evidence for the failure of a B cell subpopulation to be expressed.

Authors:  I Scher
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

6.  Ability of spleen, peritoneal cavity, and lymph node B cells to reconstitute serum immunoglobulin in SCID mice.

Authors:  J Riggs; R Stowers
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

7.  Allotypic specificities of murine IgD and IgM recognized by monoclonal antibodies.

Authors:  A M Stall; M R Loken
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

8.  A severe combined immunodeficiency mutation in the mouse.

Authors:  G C Bosma; R P Custer; M J Bosma
Journal:  Nature       Date:  1983-02-10       Impact factor: 49.962

9.  Expansion and functional activity of Ly-1+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice.

Authors:  I Förster; K Rajewsky
Journal:  Eur J Immunol       Date:  1987-04       Impact factor: 5.532

10.  The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice.

Authors:  K Hayakawa; R R Hardy; D R Parks; L A Herzenberg
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

View more
  2 in total

1.  DBA/2J (Mls-1a) B-cell differentiation in BALB.xid recipients.

Authors:  K Tocce; K Suppiah; C Rago; R Liberchuk; K Duffy; J Riggs
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neoformans Infection.

Authors:  Wendy A Szymczak; Michael J Davis; Steven K Lundy; Chad Dufaud; Michal Olszewski; Liise-anne Pirofski
Journal:  MBio       Date:  2013-07-02       Impact factor: 7.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.